RespireRx Pharmaceuticals (RSPID) Stock Chart & Stock Price History $0.0015 +0.00 (+114.29%) As of 06/20/2025 Add Compare Share Share Chart Stock AnalysisChartBuy This Stock RespireRx Pharmaceuticals Stock Price Performance The RespireRx Pharmaceuticals (RSPID) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 40.00%, with a year-to-date return of -40.00%. In the past month, the stock has decreased 16.67%, reflecting recent market activity. Receive RSPID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RespireRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 1 Month PerformanceN/A3 Month Performance-16.67%Year-To-Date Performance-40.00%1 Year Performance-40.00% RSPID Stock Chart for Monday, June, 23, 2025 RSPID Chart by TradingView RespireRx Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$0.00$0.00+183.33%$0.00$0.0068,641 shs$123,000.0006/12/2025$0.00$0.00$0.00$0.00258,451 shs$43,000.0006/11/2025$0.00$0.00-70.00%$0.00$0.00258,451 shs$43,000.0006/10/2025$0.00$0.00$0.00$0.002.00 million shs$145,000.0006/09/2025$0.00$0.00$0.00$0.002.00 million shs$145,000.0006/02/2025$0.00$0.00$0.00$0.001.24 million shs$108,000.0005/30/2025$0.00$0.00$0.00$0.00537,502 shs$108,000.0005/29/2025$0.00$0.00-6.25%$0.00$0.00180,000 shs$108,000.00 Related Companies iBio Stock Chart PolarityTE Stock Chart 9 Meters Biopharma Stock Chart Kaleido Biosciences Stock Chart 180 Life Sciences Stock Chart 3SBio Stock Chart 60 Degrees Pharmaceuticals Stock Chart Abcam Stock Chart Agentix Stock Chart Algernon Pharmaceuticals Stock Chart Receive RSPID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RespireRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:RSPID) was last updated on 6/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RespireRx Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RespireRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
